New drug HRS-5632 tested in healthy people for safety
NCT ID NCT06732154
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a single injection of HRS-5632 in 50 healthy adults to check its safety and how the body processes it. Participants were aged 18 to 55 and in good health. The study did not aim to treat any disease, only to gather initial safety information.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, 300052, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hormone therapy may shield menopausal hearts and brains — a trial puts it to the test
- Could vitamin d levels influence cholesterol in obese diabetes patients?
- Could a tropical oil and green exercise boost fat burning and calm your mind?
- Sugarcane supplement and exercise may team up to tame cholesterol
- Could a common cholesterol drug boost mood treatment?
- Could vinegar and fasting fix prediabetes cholesterol?